KK
IART icon

Kotler Kevin’s Integra LifeSciences IART Stock Holding History

Kotler Kevin’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.31M Buy
+427,445
New +$5.68M 1.24% 11

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kotler Kevin's IART Position: Q4 2025 in Review

Kotler Kevin opened a new position in Integra LifeSciences (IART) in Q4 2025: 427,445 shares worth $5.31M. The stake represents 1.24% of the portfolio and ranks #11 among its holdings.

204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • Kotler Kevin held 427,445 shares of Integra LifeSciences worth $5.31M as of Q4 2025.
  • Integra LifeSciences was a new Kotler Kevin position in Q4 2025.
  • Integra LifeSciences made up 1.24% of Kotler Kevin's portfolio in Q4 2025, its #11 holding.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.